NCT05237570 Minimally Invasive Sinus Lift Through the Interradicular Septum
| NCT ID | NCT05237570 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad de Murcia |
| Condition | Bone Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2021-03-02 |
| Primary Completion | 2026-12-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2021-03-02 with a primary completion date of 2026-12-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to describe a new approach for the reconstruction of the alveolar process in the sinus area. This minimally invasive approach will access the maxillary sinus through the alveolar process, elevating the sinus membrane in the area immediately above it. The regeneration may be achieved in the specific area required for dental implant placement, reducing the morbidity of the procedure.
Eligibility Criteria
Inclusion Criteria: * Patient older than 18 years. * Plaque index and bleeding index less than 30%. * Invagination of the sinus cavity in the interradicular area of the upper first molar. * Upper first molar not restorable and with height of the interradicular remnant less than 5 mm. Exclusion Criteria: * Presence of systemic disease contraindicating the intervention. * Pregnant women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05237570 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bone Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05237570 currently recruiting?
Yes, NCT05237570 is actively recruiting participants. Contact the research team at ajortiz@um.es for enrollment information.
Where is the NCT05237570 trial being conducted?
This trial is being conducted at Murcia, Spain.
Who is sponsoring the NCT05237570 clinical trial?
NCT05237570 is sponsored by Universidad de Murcia. The trial plans to enroll 20 participants.